Checkmate Pharmaceuticals, Inc.

CIK 1651431 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Checkmate Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Jun 10, 202215-12B0001104659-22-069921
Jun 7, 2022SC 13G/A0001140361-22-022206
Jun 7, 2022SC 13D/A0000941560-22-000007
Jun 3, 2022SC 13D/A0001193125-22-167219
Jun 3, 2022SC 13D0000941560-22-000006
Jun 1, 2022EFFECT9999999995-22-001653
May 31, 2022S-8 POS0001104659-22-066306
May 31, 202240000899243-22-020093
May 31, 2022POS AM0001104659-22-066303
May 31, 202240000899243-22-020075
May 31, 202240000899243-22-020091
May 31, 202240000899243-22-020079
May 31, 202240000899243-22-020081
May 31, 2022SC TO-T/A0001104659-22-066277
May 31, 202240000899243-22-020090
May 31, 202240000899243-22-020078
May 31, 2022SC 14D9/A0001193125-22-163200
May 31, 202240000899243-22-020086
May 31, 202240000899243-22-020083
May 31, 2022S-8 POS0001104659-22-066307
May 31, 202240000899243-22-020084
May 31, 2022S-8 POS0001104659-22-066304
May 31, 202225-NSE0001354457-22-000328
May 31, 20228-K0001104659-22-066299
May 20, 2022SC 14D9/A0001193125-22-156180